Bionic Eyes May Prompt New Wave of Medical Tourism By Farlyn Lucas While most people associate medical tourism with dental work, complex surgeries, or even assisted suicide, Hawaii has added yet another form of treatment to the list: Bionic eyes. It might sound like something out of a science fiction novel, but
Industry News
Industry News: Volume 1, Issue 4
CONGO's LATEST EBOLA OUTBREAK DECLARED FINISHED By Agence France-Presse Nytimes.com—KINSHASA, Democratic Republic of Congo — The government on Wednesday declared the end of the latest Ebola epidemic in the Democratic Republic of Congo, closing the file on an outbreak in the northwestern province of Equateur that killed dozens over six months. “I am happy
Industry News: Volume 1, Issue 3
This is how Amwell, Doctor on Demand predict telehealth visits will be different in the future By Tina Reed Fiercehealthcare.com - Among the biggest changes that could come out of the massive shift in telehealth use during the pandemic? Payers will increasingly encourage "virtual first" healthcare. To view the original article in its entirety, click here. Council
Industry News: Volume 1, Issue 2
Teladoc finalizes blockbuster deal with Livongo in less than 3 months By Heather Landi Fiercehealthcare.com - Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday. The deal was wrapped up quickly, in under three months, as the companies likely look to leverage the current financial tailwinds of
Industry News: Volume 1, Issue 1
Tying Health Care Investment to Performance By Brian Klepper and Jeffrey Hogan Thehealthcareblog.com - GoodRx’s planned initial public offering recently made the news, notable because the company, launched in 2011, has been profitable since 2016. Evidently, it’s become unfashionable for investors to demand proof of performance, so GoodRx’s results shone like a
Industry News: Volume 10, Issue 26
INDUSTRY NEWS Fixing the Biggest Problems in Healthcare Published on September 27, 2020 By Michael Gorton Teladoc founder, author, keynote speaker, serial entrepreneur. I build world changing companies from ideas. Healthcare is broken. If you believe that statement and you are building a company that should be part of the engine that fixes it, read
Industry News: Volume 10, Issue 25
Johnson & Johnson gears up for 60,000-person COVID-19 vaccine trial, the industry's biggest yet by Eric Sagonowsky fiercepharma.com - With several COVID-19 vaccines already in phase 3 trials and investigators aiming to enroll tens of thousands of participants, Johnson & Johnson is prepping the largest study yet. The drugmaker is planning to enroll a whopping
Industry News: Volume 10, Issue 24
Even Asymptomatic People Carry the Coronavirus in High Amounts By Apoorva Mandavilli Nytimes.com - Of all the coronavirus’s qualities, perhaps the most surprising has been that seemingly healthy people can spread it to others. This trait has made the virus difficult to contain, and continues to challenge efforts to identify and isolate infected people. To view the
Industry News: Volume 10, Issue 23
Economic analysis of the prevalence and clinical and economic burden of medication error in England By Rachel Ann Elliott, Elizabeth Camacho, Dina Jankovic, Mark J Sculpher, Rita Faria Qualitysafety.bmj.com - Medication is the most widely used medical intervention. Harm caused by medication is referred to as an adverse drug event (ADE), and includes medication errors,
Industry News: Volume 10, Issue 22
INDUSTRY NEWS Johnson & Johnson to End Talc-Based Baby Powder Sales in North America By Tiffany Hsu and Roni Caryn Rabin nytimes.com - Johnson & Johnson is discontinuing North American sales of its talc-based baby powder, a product that once defined the company’s wholesome image and that it has defended for decades even as it faced